ArticleFrontiers in oncology2022

Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis.

Yanlin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.